The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webinars
Explore common indirect spend risk considerations and prepare to take steps to introduce resiliency within indirect spend categories.
e-Learning
An introduction to environmental sustainability walking learners through strategizing on simple projects while outlining commitment to sustainability…
Blog
Read a sponsored blog from Owens & Minor to learn how staff can spend less time on manual tasks and more time on patient care.
White Papers
A detailed example of a new Master of Health Administration (MHA) program with a medical logistics concentration.
AHRMM What's New
Supply chain teams across the U.S. continue to face supply shortages.